Profilo
Hakon Leffler is the founder of Galecto Biotech ApS and Galecto, Inc. which were both founded in 2011.
He is currently a Director at Lundonia Biotech AB and a Professor at the University of Lund.
He was previously a Principal at the University of California, San Francisco.
Posizioni attive di Hakon Leffler
| Società | Posizione | Inizio |
|---|---|---|
Lundonia Biotech AB
Lundonia Biotech AB Miscellaneous Commercial ServicesCommercial Services Provides academic as well as industrial research and development with diagnostic tools | Direttore/Membro del Consiglio | 06/07/2009 |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Hakon Leffler
| Società | Posizione | Fine |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| DAMORA THERAPEUTICS, INC. | Fondatore | - |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundonia Biotech AB
Lundonia Biotech AB Miscellaneous Commercial ServicesCommercial Services Provides academic as well as industrial research and development with diagnostic tools | Commercial Services |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
















